NVO: Novo Nordisk A/S

56.47 USD 0.38 (0.68%)

부문: 헬스케어 베이스: US Dollar 수익 통화: US Dollar

NVO 환율이 오늘 0.68%로 변동했습니다. 당일 이 종목은 저가가 55.71이고 고가는 56.52이었습니다.

Novo Nordisk A/S 변동을 참고하세요. 실시간 쿼트는 여러분이 시장 변동에 빠르게 대처하는데에 도움이 될 것입니다. 차트 주기를 전환하여 환율의 추세와 변동을 분, 시간, 일, 주 및 월별로 모니터링할 수 있습니다. 이 정보를 사용하여 시장 변화를 예측하고 정보에 입각한 거래 결정을 내리십시오.

전체 화면 채팅

NVO News

18:00 Mounjaro Price Bomb Sparks UK Pharmacy Rebellion--Wegovy Cashes In
18:58 Teva Launches Generic GLP-1 Weight Loss Drug With FDA Nod For Saxenda - Teva Pharmaceutical Indus (NYSE:TEVA)
18:35 Wall Street Lunch: 'Economy Is Slowing, But Still Clearly Growing'
17:37 Prothena Reports Non-Competitive Brain Swelling Rates In Early Alzheimer's Study - Eli Lilly (NYSE:LLY), Biogen (NASDAQ:BIIB)
14:50 FDA Approves First-Ever Generic Weight-Loss Drug In A Blow To Novo Nordisk
14:05 Piper Sandler slashes Prothena stock price target to $15 from $81 on PRX012 data
12:00 Novo Nordisk Eyes New Arena Amid Weight-Loss Market Pressure
10:29 UK Patients Scramble For Mounjaro As Eli Lilly's 170% Price Hike Plan Sparks Shortages, Health Fears - Eli Lilly (NYSE:LLY)
07:26 2 High-Yield Dividend Stocks You Can Buy With $200 Now and Hold at Least a Decade
03:04 Tracking Terry Smith’s Fundsmith 13F Portfolio – Q2 2025 Update
14:52 Novo Nordisk vs. Viking Therapeutics: Which GLP-1 Stock is a Safer Bet?
13:43 Eli Lilly stock rating reiterated at Outperform by BMO on orforglipron data
13:21 Eli Lilly stock maintains Buy rating at UBS after positive obesity drug data
12:14 HSBC upgrades Eli Lilly to Hold, says ’bear case has played out’
12:11 Does Lilly's New Obesity Pill Data Put It Back in the Weight Game?
12:08 LLY vs. PFE: Which Pharma Giant Is the Better Pick for Investors?
11:25 The bear case on Eli Lilly has played out, says only firm to have called it a sell
04:15 Thornburg Global Opportunities Fund Q2 2025 Commentary
01:15 Eli Lilly (LLY) Prepares for Weight Loss Pill Approval After Late-Stage Clinical Trial - TipRanks.com
22:23 Why Novo Nordisk Stock Tumbled on Tuesday
18:53 Gyre Therapeutics Gains Attention As Under-The-Radar Liver Fibrosis Drug Maker - Gyre Therapeutics (NASDAQ:GYRE)
16:10 Novo Nordisk Stock (NVO) Slides on Rival Weight Loss Pill News - TipRanks.com
15:09 Can Novo Nordisk Offset GLP-1 Pressures With Rare Disease Wins?
14:28 Factbox-Top pharma companies work to launch first weight-loss pill

일일 변동 비율

55.71 56.52

년간 변동

46.90 138.62

이전 종가: 56.09
시가: 56.06

Bid: 56.47
Ask: 56.77

저가: 55.71
고가: 56.52

볼륨: 15.758 K

일일 변동: 0.68%
월 변동: 16.99%

6개월 변동: -37.71%
년간 변동율: -59.25%

30 8월, 토요일